Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China · Delayed Price · Currency is CNY 7.53
-0.20 (-2.59%)
At close: Apr 17, 2026
SHA:688189 Revenue
Hunan Nucien Pharmaceutical had revenue of 21.31M CNY in the quarter ending September 30, 2025, a decrease of -40.45%. This brings the company's revenue in the last twelve months to 95.33M, down -76.70% year-over-year. In the year 2024, Hunan Nucien Pharmaceutical had annual revenue of 263.28M, down -63.44%.
Revenue (ttm)
95.33M
Revenue Growth
-76.70%
P/S Ratio
22.10
Revenue / Employee
260.46K
Employees
319
Market Cap
2.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 263.28M | -456.78M | -63.44% |
| Dec 31, 2023 | 720.06M | 21.24M | 3.04% |
| Dec 31, 2022 | 698.83M | -44.83M | -6.03% |
| Dec 31, 2021 | 743.66M | -285.48M | -27.74% |
| Dec 31, 2020 | 1.03B | 14.92M | 1.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 886.96M |
| Chengdu huasun technology group Inc. , LTD. | 545.50M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 462.78M |
| Anhui Huangshan Capsule | 460.42M |
| Guhan Pharmaceutical Group | 337.67M |